Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network

Yannick Le Bris, Barbara Burroni, Marguerite Fournier, Morgane Cheminant, Sara Ek, Eva Hoster, Marie-Helene Delfau-Larue, Clémentine Sarkozy, Mary B. Callanan, Benoit Tessoulin, David Chiron, Martin Dreyling, Mats Jerkeman, Steven Le Gouill, Olivier Hermine

Blood (2024) 144 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2024-199152

Published: 2024

Journal Articles

The Composition of Macrophages Has Prognostic Impact in Diffuse Large B-Cell Lymphoma By Spatial Omic Studies

Angelica Johansson, Daniel Nilsson, Lina M Olsson, Edith Gustafsson, Niamh Nihlsson, Anna Janska, Anna Porwit, Peter Hollander, Mats Jerkeman, Sara Ek

Blood (2024) 144 (Supplement 1): 2987.

https://doi.org/10.1182/blood-2024-201430

Published: 2024

Journal Articles

A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21 R110

Blood (2022) 140 (Supplement 1): 1800–1802.

https://doi.org/10.1182/blood-2022-165181

Published: 2022

Journal Articles

Exploring New Prognostic Biomarkers in Mantle Cell Lymphoma: The Best RNA Based Risk Score

Ruth Salim, Simon Husby, Christian Winther Eskelund, David W. Scott, Harald Holte, Arne Kolstad, Riikka Räty, Sara Ek, Mats Jerkeman, Christian H. Geisler, Lasse Sommer Kristensen, Mette Dahl, Kirsten Grønbæk

Blood (2022) 140 (Supplement 1): 9254–9256.

https://doi.org/10.1182/blood-2022-159472

Published: 2022

Journal Articles

Unraveling Actionable Target Mutations in Formalin Fixed Tissue in Mantle Cell Lymphoma

Joana M. Rodrigues, May Hassan, Msc., Anna Porwit, Sara Ek, PhD Professor, Mats Jerkeman, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-136944

Published: 2020

Journal Articles

A Circular RNA Molecule, circRAB11FIP1, Is Associated with TP53 Mutations and Is of Potential Prognostic and Functional Significance in Mantle Cell Lymphoma: Data from the Nordic MCL2 and MCL3 Studies

Mette Dahl, MD, Simon Husby, MD, Christian Winther Eskelund, MD, Christophe Côme, PhD, Sara Ek, PhD Professor, Arne Kolstad, MD PhD, Riikka Räty, PhD Associate professor, Mats Jerkeman, MD Professor, Christian H. Geisler, MD PhD, Lasse Sommer Kristensen, PhD Assistant professor, Kirsten Grønbæk, Professor, MD DMSc

Blood (2019) 134 (Supplement_1): 1495.

https://doi.org/10.1182/blood-2019-123989

Published: 2019

Journal Articles

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

Agata Magdalena Wasik, PhD MSc, Elin Marin, MD, Magali Merrien, MSc, Joana de Matos Rodrigues, PhDstudent, Martin Lord, PhD, Ioanna Xagoraris, MD, Birger Christensson, MD PhD, George Rassidakis, MD PhD, Mats Jerkeman, Sara Ek, PhD, Birgitta Sander, MD PhD

Blood (2018) 132 (Supplement 1): 4136.

https://doi.org/10.1182/blood-2018-99-118087

Published: 2018

Journal Articles

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Blood (2017) 130 (Supplement 1): 57.

https://doi.org/10.1182/blood.V130.Suppl_1.57.57

Published: 2017

Journal Articles

Ibrutinib in Combination with Anti-CD20-Antibody Negatively Affects Antibody Dependent Cellular Cytotoxic (ADCC) on Mantle Cell Lymphoma Cell Lines, Not Reversed By the Addition of Lenalidomide

Mats Jerkeman, MD PhD, Sara Ek, PhD, Catja Freiburghaus, PhD, Alexandra Albertsson Lindblad

Blood (2017) 130 (Supplement 1): 1266.

https://doi.org/10.1182/blood.V130.Suppl_1.1266.1266

Published: 2017

Journal Articles

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Christian W. Eskelund, Christina Dahl, Jakob W. Hansen, Maj Westman, Arne Kolstad, Lone B. Pedersen, Carmen P. Montano-Almendras, Simon Husby, Catja Freiburghaus, Sara Ek, Anja Pedersen, Carsten Niemann, Riikka Räty, Peter Brown, Christian H. Geisler, Mette K. Andersen, Per Guldberg, Mats Jerkeman, Kirsten Grønbæk

Blood (2017) 130 (17): 1903–1910.

https://doi.org/10.1182/blood-2017-04-779736

Published: 2017

Includes: Supplemental data

Journal Articles

Resistance to Cytarabine in Mantle Cell Lymphoma Is Mediated By Down-Regulation of Deoxycytidine Kinase at the Protein Level

Catja Freiburghaus, PhD, Venera Kuci Emruli, PhD, Angelica Johansson, Roger Olsson, PhD, Fredrik Ek, PhD, Christian H Geisler, Mats Jerkeman, Sara Ek, PhD

Blood (2016) 128 (22): 1769.

https://doi.org/10.1182/blood.V128.22.1769.1769

Published: 2016

Journal Articles

Targeted Sequencing of Diagnostic Samples Correlated to Clinical Outcome: Data from the Nordic Mantle Cell Lymphoma (MCL2 and MCL3) Studies with Long-Term Follow-up

Christian Winther Eskelund, Jakob W Hansen, Maj Karoline Westman, MSc, Catja Freiburghaus, PhD, Sara Ek, PhD, Lone B Pedersen, Mette K Andersen, Riikka Räty, Arne Kolstad, Mats Jerkeman, Peter de Nully Brown, MD PhD, Christian H Geisler, Kirsten Groenbaek

Blood (2016) 128 (22): 1095.

https://doi.org/10.1182/blood.V128.22.1095.1095

Published: 2016

Journal Articles

Frequency and Clinical Implication of SOX11 Expression in Burkitt Lymphoma

Tove Wästerlid, MD, Lena Nordström, MSc, PhD, Mette Pedersen, MD PhD, Peter H Norgaard, MD PhD, Anne Ortved Gang, MDPhD, Peter de Nully Brown, MDPhD, Mats Jerkeman, MD PhD, Sara Ek, PhD

Blood (2015) 126 (23): 5039.

https://doi.org/10.1182/blood.V126.23.5039.5039

Published: 2015

Journal Articles

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Blood (2015) 125 (17): 2669–2677.

https://doi.org/10.1182/blood-2014-06-584193

Published: 2015

Includes: Supplemental data

Journal Articles

Diagnostic Tumor Mirna Profiling Predicts Molecular Relapse in Mantle Cell Lymphoma Patients Prospectively Followed for Minimal Residual Disease. Results from the Nordic MCL2-3 Trials

Simon Husby, MD, Lone Bredo Pedersen, Ulrik Ralfkiær, PhD-student, Christian Garde, Sara Ek, Arne Kolstad, MD PhD, Mats Jerkeman, MD PhD, Anna Laurell, Riikka Räty, Anja Pedersen, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, MD PhD, Erik Clasen-Linde, MD, Christopher Workman, PhD, Christian H Geisler, Kirsten Grønbæk, MD DMSc

Blood (2014) 124 (21): 2994.

https://doi.org/10.1182/blood.V124.21.2994.2994

Published: 2014

Journal Articles

Increased Expression Levels Of SOX11 Correlates To Overall Survival and Adds Prognostic Value To The MIPI and MIPI-B Index In a Homogenously Treated Cohort

Lena Nordström, Venera Kuci, Sandra Sernbo, Kirsten Groenbaek, MD, DMSc, Arne Kolstad, Riika Räty, Marja-Liisa Karjalainen, Christian Geisler, Elisabeth Ralfkiaer, MD, DMSc, Christer Sundström, Anna Laurell, Jan Delabie, Mats Ehinger, Mats Jerkeman, Sara Ek

Blood (2013) 122 (21): 4272.

https://doi.org/10.1182/blood.V122.21.4272.4272

Published: 2013

Journal Articles

Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference

Eva Ortega-Paino, Johan Fransson, Sara Ek, Carl A. K. Borrebaeck

Blood (2008) 111 (3): 1617–1624.

https://doi.org/10.1182/blood-2007-02-068791

Published: 2008

Journal Articles

Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

Sara Ek, Michael Dictor, Mats Jerkeman, Karin Jirström, Carl A. K. Borrebaeck

Blood (2008) 111 (2): 800–805.

https://doi.org/10.1182/blood-2007-06-093401

Published: 2008

Journal Articles

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Erik Björck, Sara Ek, Ola Landgren, Mats Jerkeman, Mats Ehinger, Magnus Björkholm, Carl A. K. Borrebaeck, Anna Porwit-MacDonald, Magnus Nordenskjöld

Blood (2005) 105 (7): 2908–2915.

https://doi.org/10.1182/blood-2004-07-2721

Published: 2005

NARROW

Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network

The Composition of Macrophages Has Prognostic Impact in Diffuse Large B-Cell Lymphoma By Spatial Omic Studies

A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21 R110

Exploring New Prognostic Biomarkers in Mantle Cell Lymphoma: The Best RNA Based Risk Score

Unraveling Actionable Target Mutations in Formalin Fixed Tissue in Mantle Cell Lymphoma

A Circular RNA Molecule, circRAB11FIP1, Is Associated with TP53 Mutations and Is of Potential Prognostic and Functional Significance in Mantle Cell Lymphoma: Data from the Nordic MCL2 and MCL3 Studies

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Ibrutinib in Combination with Anti-CD20-Antibody Negatively Affects Antibody Dependent Cellular Cytotoxic (ADCC) on Mantle Cell Lymphoma Cell Lines, Not Reversed By the Addition of Lenalidomide

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Resistance to Cytarabine in Mantle Cell Lymphoma Is Mediated By Down-Regulation of Deoxycytidine Kinase at the Protein Level

Targeted Sequencing of Diagnostic Samples Correlated to Clinical Outcome: Data from the Nordic Mantle Cell Lymphoma (MCL2 and MCL3) Studies with Long-Term Follow-up

Frequency and Clinical Implication of SOX11 Expression in Burkitt Lymphoma

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Diagnostic Tumor Mirna Profiling Predicts Molecular Relapse in Mantle Cell Lymphoma Patients Prospectively Followed for Minimal Residual Disease. Results from the Nordic MCL2-3 Trials

Increased Expression Levels Of SOX11 Correlates To Overall Survival and Adds Prognostic Value To The MIPI and MIPI-B Index In a Homogenously Treated Cohort

Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference

Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only